A detailed history of Royal Bank Of Canada transactions in Iradimed Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 23,374 shares of IRMD stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,374
Previous 19,247 21.44%
Holding current value
$1.28 Million
Previous $845,000 39.05%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$43.23 - $50.29 $178,410 - $207,546
4,127 Added 21.44%
23,374 $1.18 Million
Q2 2024

Aug 14, 2024

BUY
$40.36 - $44.7 $55,737 - $61,730
1,381 Added 7.73%
19,247 $845,000
Q1 2024

Nov 05, 2024

SELL
$41.17 - $47.29 $56,855 - $65,307
-1,381 Reduced 7.18%
17,866 $785,000
Q1 2024

May 15, 2024

BUY
$41.17 - $47.29 $635,952 - $730,488
15,447 Added 638.57%
17,866 $785,000
Q4 2023

Feb 14, 2024

BUY
$37.31 - $47.47 $49,696 - $63,230
1,332 Added 122.54%
2,419 $114,000
Q3 2023

Nov 14, 2023

BUY
$43.28 - $50.3 $25,968 - $30,180
600 Added 123.2%
1,087 $48,000
Q2 2023

Aug 14, 2023

SELL
$38.88 - $50.61 $17,729 - $23,078
-456 Reduced 48.36%
487 $23,000
Q1 2023

May 15, 2023

SELL
$28.48 - $42.14 $13,072 - $19,342
-459 Reduced 32.74%
943 $37,000
Q4 2022

Feb 14, 2023

BUY
$26.9 - $30.58 $27,249 - $30,977
1,013 Added 260.41%
1,402 $39,000
Q3 2022

Nov 14, 2022

BUY
$29.42 - $42.25 $2,088 - $2,999
71 Added 22.33%
389 $12,000
Q2 2022

Aug 15, 2022

SELL
$30.15 - $45.79 $10,160 - $15,431
-337 Reduced 51.45%
318 $10,000
Q1 2022

May 16, 2022

SELL
$36.01 - $53.14 $41,411 - $61,111
-1,150 Reduced 63.71%
655 $29,000
Q4 2021

Feb 14, 2022

BUY
$32.35 - $48.27 $37,202 - $55,510
1,150 Added 175.57%
1,805 $84,000
Q3 2021

Nov 15, 2021

BUY
$29.5 - $37.21 $5,280 - $6,660
179 Added 37.61%
655 $23,000
Q2 2021

Aug 16, 2021

BUY
$24.04 - $29.79 $11,443 - $14,180
476 New
476 $14,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $687M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.